APA (7th ed.) Citation

Okano, N., Mizutani, T., Nagashima, F., & Furuse, J. (2021). Stereotactic body radiotherapy plus pembrolizumab and trametinib for pancreatic cancer. The Lancet Oncology, 22(10), e423. https://doi.org/10.1016/S1470-2045(21)00489-7

Chicago Style (17th ed.) Citation

Okano, Naohiro, Tomonori Mizutani, Fumio Nagashima, and Junji Furuse. "Stereotactic Body Radiotherapy Plus Pembrolizumab and Trametinib for Pancreatic Cancer." The Lancet Oncology 22, no. 10 (2021): e423. https://doi.org/10.1016/S1470-2045(21)00489-7.

MLA (9th ed.) Citation

Okano, Naohiro, et al. "Stereotactic Body Radiotherapy Plus Pembrolizumab and Trametinib for Pancreatic Cancer." The Lancet Oncology, vol. 22, no. 10, 2021, p. e423, https://doi.org/10.1016/S1470-2045(21)00489-7.